Found 471 investors
G.N. Tech Venture Capital
South Korea
G.N. Tech Venture Capital is the corporate venture capital arm of Kook Soon Dang Company and is based in South Korea. The firm seeks to invest in the healthcare and biotechnology sectors, with a focus on South Korea.
Venture Capital
Gobi-Hitech Investment
China
Founded in 2008, Gobi-Hitech Investment is an early and growth stage joint venture established in Tianjin by Tianjin Haitai Technology Investment Management and Gobi Partners. The firm seeks to make investments in sectors like TMT, biotechnology, information technology, new energy and renewable energy, nano and new materials, civil aviation technology industry, as well as key industries in the future Tianjin Binhai High-tech Zone.
Venture Capital
Gonzalo Utrilla
United States
Mr. Paul Intlekofer founded and served as Chief Executive Officer at MMG Fusion. He serves as President, Chief Financial Officer and Managing Partner at SFP Capital. Mr. Paul Intlekofer is the President of SFP Capital. Previously he was the Executive Vice President and Chief Marketing Officer of Medifast. As EVP, Chief Marketing Officer of Medifast, Inc. (NYSE: Med) Paul managed and directed the largest business units and led sales, marketing, and customer service driving revenue increases from $75MM to $275MM in three years. He turned around an underperforming Direct Response division and call center, creating improved profits from $4MM to $22MM and led the growth of its Direct Sales division from $40MM to $160MM. Medifast was ranked as the #1 Small Cap U.S. Company in 2010 by Forbes, two years after Paul joined the Company. In 2002 Paul joined Nutrition 21, a biotechnology company, to help it secure financing for R&D and to commercialize its technology. When the clinical trials failed, Paul was promoted to CEO, transformed the business and grew revenues from $10MM to $46MM in three years. The company was recognized by Nutrition Business Journal in 2006 for Acquisition of the Year, and in 2007 for Fastest Growing Small Cap Company.
Individual/Angel
Good Insight
China
Founded in 2009, Good Insight is an early and growth-stage venture capital firm based in Hubei, China. The firm seesk to make investments in sectors like Modern manufacturing, new materials, new energy, medical equipment, biotechnology, hospitals and chain medical institutions, emerging service industries, high-tech agriculture, branded consumer goods, and media.
Venture Capital
GP Healthcare Capital
Shanghai, Shanghai, China
GP Healthcare Capital is a venture capital that makes investments in companies based in the biotechnology industry.
Asset Management
Finance
Financial Services
Management Consulting
Private Equity Firm
Grace Harbor Capital
South Korea
Founded in 2003, NAU IB Capital is a private equity firm headquartered in Seoul, South Korea. The firm seeks to invest in companies operating in the pharmaceuticals, biotechnology, and life sciences sectors
Private Equity Firm
Grant Investment Group
United States
Grant Investment Group was an investment management firm that managed equity options portfolios and healthcare funds of various sectors, such as biotechnology, pharmaceuticals, medical device, technology and internet. The firm was based in Overland Park, Kansas.
Private Equity Firm
Green Innovations
Malta
Green Innovations is an venture capital firm based in Qormi, Malta. The firm seeks to invest in green technology, biotechnology, agriculture, housing, water, energy, telecom and education sectors.
Venture Capital
Growth Factor BioCapital
Spain
Founded in 2013, Growth Factor Biocapital is a venture capital firm based in Madrid, Spain. The firm prefers to invest in early-stage and growth-stage companies. The firm seeks investments in the biotechnology industry based in Spain.
Venture Capital
Gruender Motor
United States
Dr. Richard Klausner is a Co-Founder and serves as the Chairman at LifeMine. He is a Co-Founder and serves as Chief Scientist & Chairman at Atlos Labs. He is the Founder and serves as the Executive Chairman & Board Member at Lyell. He is a Co-Founder and serves as the Executive Chairman at Mindstrong. He serves as Chairman at Sonoma Biotherapeutics. He serves as Board Member and Advisor at Orca Bio. Previously, he served as Chief Executive Officer and Board Member at Lyell. Dr. Richard Klausner is a Co-Founder & serves as Board Member at Juno Therapeutics. He served as the Chief Medical Officer & Senior Vice President at Illumina. He is a Scientific Advisor at Aragon Pharmaceuticals. He serves as a Board Member and Scientific Advisor at Grail (Biotechnology). He is the former Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was a Board Member at Audax. He was the eleventh director of the National Cancer Institute between 1995 and 2001. His research has been recognized with awards including the Outstanding Investigator Award from the American Federation of Clinical Research and the William Damashek Prize for major discoveries in hematology. He received the 1997-1998 Dickson Prize in Medicine and the 1998 Raymond Bourgine Award. He has served as an Advisor to the Presidents of the Academies for Counter-terrorism and Liaison to the White House Office of Science & Technology Policy. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner is a past president of the American Society of Clinical Investigation and has been Chairman of the National Science Education Standards Projects of the National Academy of Sciences. He previously served as the Chief Medical Officer and Senior Vice President at The Column Group. Dr. Klausner currently chairs the International Advisory Board for Samsung, is the Chairman of Audax Health, and previously chaired the Strategic Oversight Council of Sanofi. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner holds an M.D. from Duke Medical School. He serves as Chairman at Xtremity.
Individual/Angel
Grupo Genetrix
Madrid, Madrid, Spain
Genetrix, created to promote entrepreneurial leaders in the biotechnology sector, is a group of companies aimed at generating value from
Biotechnology
Health Care
Medical
Venture Capital
GUB Management
Germany
GUB Management is a venture capital investment firm that is based in Schwäbisch Hall, Germany. The firm was incorporated in 1994 and prefers to invest in young high-technology companies operating in the healthcare, medical, renewable energy, biotechnology and information technology sectors.
Venture Capital
Guizhou Ventures Capital
China
Founded in 1998, Guizhou Ventures Capital is a Guizhou province state-owned venture capital firm based in Guizhou, China. The firm seeks to make investments in traditional industrial and High-tech industries such as materials, advanced manufacturing, SaaS, Hardware, and biotechnology.
Venture Capital
Gyeongnam Venture Investment
South Korea
Founded in 2019, Gyeongnam venture investment is a venture capital investment firm based in Gyeongsangnam-Do, South Korea. The firm prefers to invest in the internet, communication, IoT, electricity, electronics, semiconductors, materials, automobiles, healthcare, biotechnology, cultural contents such as movies, performances, musicals and other industries with growth potential sectors.
Venture Capital
Hamraj Kumar
Italy
Mr. Harald Oberrauch serves as Vice-President of the Board at Covision Lab. He is the Founder & Owner of Tyrolean Business Angel. Mr. Harald Oberrauch serves as Board Observer at Immagina Biotechnology. He is also an Angel Investor. He is also President of Durst Group AG, President of Alupress AG and Founder of TBA - Tyrolean Business Angel.
Individual/Angel
Hanhai Plug and Play
China
Hanhai Plug and Play wass an accelerator that sought to invest in the educational services, media, entertainment, biotechnology and information technology sectors. The firm wass based in Zhegzhou City, China.
Accelerator
Incubator
Hans Kupper
Munich, Bayern, Germany
Dr. Hans Kupper is a partner at Global Life Science Ventures since 1999. Dr Kupper has 29 years of experience in biotechnology with 19 years...
Investment Partner
HardGamma Ventures
Warsaw, Mazowieckie, Poland
HardGamma Ventures is a venture capital fund that invests in startups that focuses on computing, internet, biotechnology, and more.
Finance
Financial Services
FinTech
Venture Capital
Venture Capital
HardTech Labs
United States
HardTech Labs is an accelerator program that gives startups operating in the hardware and biotech sectors access to low-cost manufacturing. The firm was founded in 2014 and is based in Del Mar, California. It seeks to invest in the hardware, software or biotechnology products, sensors, diagnostics and medical devices firms.
Accelerator
Incubator
Harry Hyman
United States
Dr. Una Ryan served as Managing Director at Golden Seeds. She is a Board Member of Cortexyme .She is currently Research Professor of Medicine at BU School of Medicine and serves on its Board of Visitors. Her board positions include AMRI (Lead Director, Nominating and Compensation committees) and MSH (Audit and Compensation committees). She was most recently President and CEO of Diagnostics For All (DFA), a non-profit organization developing inexpensive diagnostics for global health and agricultural uses. Previously, she was President and CEO of AVANT Immunotherapeutics, Inc, (NASDAQ) a company developing vaccines and immunotherapeutics for cancer, travellers, food safety and global health and also a member of its Board of Directors. Prior to AVANT, she was director of Health Sciences at Monsanto Company. Before that, she held a number of positions in academia, including Research Professor of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine. She was also Chair of the Massachusetts Biotechnology Council, served on its Board, as well as the Biotechnology Industry Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy and Policy Council of the MIT Center for Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering and mathematics education. She holds a PhD in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology and Chemistry from Bristol University. She received an Honorary Doctor of Science degree from Bristol University in 2009. In 2007, she received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002 Her Majesty Queen Elizabeth II awarded she the Order of the British Empire (OBE) for services to research, development and promotion of biotechnology. She is also an Angel Investor. She also served as a Board Member at EMulate Therapeutics.
Individual/Angel
Showing 181 to
200 of
471 results